AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29029049 — intervention group
Group type: EXPERIMENTAL
Intervention: High-remifentanil with naloxone (4 ng ml-1 remifentanil with 0.05 μg kg-1 h-1 naloxone)
Number of subjects: 91
Study 29029049 — intervention group
Group type: COMPARATOR
Intervention: High-remifentanil (4 ng ml-1 remifentanil)
Number of subjects: 91
Study 29029049 — intervention group
Group type: COMPARATOR
Intervention: Low-remifentanil (1 ng ml-1 remifentanil)
Number of subjects: 91
Study 29029049 — intervention group
Group type: COMPARATOR
Intervention: High-remifentanil
Number of subjects: 91
Study 29029049 — intervention group
Group type: EXPERIMENTAL
Intervention: High-remifentanil with naloxone
Number of subjects: 91
Study 29029049 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-remifentanil
Number of subjects: 91
Study 29029049 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 91
Study 26371617 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) plus treatment-as-usual (TAU)
Number of subjects: 106
Study 26371617 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral analysis system of psychotherapy (CBASP) plus treatment-as-usual (TAU)
Number of subjects: 106
Study 26371617 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 106
Study 23591273 — intervention group
Group type: EXPERIMENTAL
Intervention: Numeric literacy (Asthma Numeracy Questionnaire)
Number of subjects: 284
Study 23591273 — intervention group
Group type: EXPERIMENTAL
Intervention: Print literacy (Short Test of Functional Health Literacy in Adults)
Number of subjects: 284
Study 21210958 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimacy-Enhancing Therapy (IET)
Number of subjects: 71
Study 21210958 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 71
Study 19490594 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 6000
Study 19490594 — intervention group
Group type: COMPARATOR
Intervention: Intermediate target range for blood glucose
Number of subjects: 6000
Study 16760445 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (1 g single dose)
Number of subjects: 195
Study 16760445 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin (1 g single dose)
Number of subjects: 195
Study 16760445 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 195
Study 16760445 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 195
Study 14757848 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ-123 (60 microg/min for 30 min) during placebo clamp conditions
Number of subjects: 20
Study 14757848 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ-123 (60 microg/min for 30 min) during euglycemic hyperinsulinemia (3 mU/kg/min for 390 min)
Number of subjects: 20
Study 14757848 — intervention group
Group type: COMPARATOR
Intervention: Placebo during euglycemic hyperinsulinemia
Number of subjects: 20
Study 14757848 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ-123 (32 microg/min for 120 min) during placebo or insulin clamp
Number of subjects: 20
Study 11211371 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 to 200 mg/day
Number of subjects: 120
Study 11211371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 11211371 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 120
Study 9559411 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (140 micrograms/kg per min)
Number of subjects: 16
Study 9559411 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (20 micrograms/kg per min)
Number of subjects: 16
Study 9559411 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 16
Study 7862784 — intervention group
Group type: EXPERIMENTAL
Intervention: MMPI
Number of subjects: 133
Study 7862784 — intervention group
Group type: EXPERIMENTAL
Intervention: Millon
Number of subjects: 133
Study 2656623 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole (2 g intra-operative iv dose)
Number of subjects: 36
Study 2656623 — intervention group
Group type: COMPARATOR
Intervention: Cefotetan (2 g intra-operative iv dose)
Number of subjects: 36
Study 4943034 — intervention group
Group type: EXPERIMENTAL
Intervention: Penfluridol 30 mg weekly oral dose
Number of subjects: 30
Study 30508094 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet fortified with a Zn AA complex (2 × NRC)
Number of subjects: 16
Study 30508094 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet fortified with ZnSO4 (2 × NRC)
Number of subjects: 16
Study 30508094 — intervention group
Group type: COMPARATOR
Intervention: Control diet without fortified Zn (1 × NRC)
Number of subjects: 16
Study 28645191 — intervention group
Group type: EXPERIMENTAL
Intervention: ALGO DE (n=91)
Number of subjects: 440
Study 28645191 — intervention group
Group type: EXPERIMENTAL
Intervention: ALGO SW (n=89)
Number of subjects: 440
Study 28645191 — intervention group
Group type: EXPERIMENTAL
Intervention: ALGO LA (n=86)
Number of subjects: 440
Study 28645191 — intervention group
Group type: COMPARATOR
Intervention: TAU (n=84)
Number of subjects: 440
Study 28645191 — intervention group
Group type: COMPARATOR
Intervention: CDES (n=79)
Number of subjects: 440
Study 25982053 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 39
Study 25982053 — intervention group
Group type: COMPARATOR
Intervention: CsA
Number of subjects: 39
Study 23690582 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin treatment (folic acid 0.8 mg, vitamin B6 20 mg, vitamin B12 0.5 mg)
Number of subjects: 0
Study 23690582 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin treatment
Number of subjects: 0
Study 23690582 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study 21486960 — intervention group
Group type: EXPERIMENTAL
Intervention: TBR-652 (25, 50, 75, 100, and 150 mg)
Number of subjects: 10
Study 21486960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 19909421 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE (Creating Opportunities for Personal Empowerment) Healthy Lifestyles TEEN program
Number of subjects: 19
Study 19909421 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE program (subset of 7 overweight adolescents)
Number of subjects: 19
Study 19909421 — intervention group
Group type: COMPARATOR
Intervention: Attention control program
Number of subjects: 19
Study 16977280 — intervention group
Group type: EXPERIMENTAL
Intervention: Gardasil (recombinant quadrivalent human‐papillomavirus‐like particle vaccine)
Number of subjects: 0
Study 12757345 — intervention group
Group type: EXPERIMENTAL
Intervention: Single aortic clamp (SAC)
Number of subjects: 268
Study 12757345 — intervention group
Group type: COMPARATOR
Intervention: Partial occluding clamp (POC)
Number of subjects: 268
Study 10883664 — intervention group
Group type: EXPERIMENTAL
Intervention: IdUrd
Number of subjects: 65
Study 10883664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclin A
Number of subjects: 65
Study 10883664 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki‐67
Number of subjects: 65
Study 9339548 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn peptide (CP)
Number of subjects: 10
Study 9339548 — intervention group
Group type: COMPARATOR
Intervention: Wheat peptide (WP)
Number of subjects: 10
Study 9339548 — intervention group
Group type: COMPARATOR
Intervention: Alanine
Number of subjects: 10
Study 9339548 — intervention group
Group type: COMPARATOR
Intervention: Leucine
Number of subjects: 10
Study 9339548 — intervention group
Group type: COMPARATOR
Intervention: Pea peptide (PP)
Number of subjects: 10
Study 9339548 — intervention group
Group type: COMPARATOR
Intervention: Control (no peptide)
Number of subjects: 10
Study 8245265 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved cultured epidermal allografts (CCAs)
Number of subjects: 43
Study 8245265 — intervention group
Group type: COMPARATOR
Intervention: Hydrocolloid dressings (HCDs)
Number of subjects: 43
Study 4050315 — intervention group
Group type: EXPERIMENTAL
Intervention: Paralgin forte
Number of subjects: 0
Study 4050315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 4050315 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive instructions
Number of subjects: 0
Study 4050315 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative instructions
Number of subjects: 0
Study 4050315 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral instructions
Number of subjects: 0
Study 30464407 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted condition (entecavir administration)
Number of subjects: 96
Study 30464407 — intervention group
Group type: COMPARATOR
Intervention: Fed condition (entecavir administration)
Number of subjects: 96
Study 27071819 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight (BMI 25 to <30 kg/m2)
Number of subjects: 17913
Study 27071819 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese (BMI ≥30 kg/m2)
Number of subjects: 17913
Study 27071819 — intervention group
Group type: EXPERIMENTAL
Intervention: High waist circumference (WC) in women
Number of subjects: 17913
Study 25390467 — intervention group
Group type: EXPERIMENTAL
Intervention: Early palliative care
Number of subjects: 0
Study 25390467 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician roles in early palliative care
Number of subjects: 0
Study 20231857 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (4 mg as gum)
Number of subjects: 31
Study 20231857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 19695099 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-pro BNP monitoring
Number of subjects: 42
Study 19695099 — intervention group
Group type: COMPARATOR
Intervention: NT-pro BNP levels
Number of subjects: 42
Study 17669629 — intervention group
Group type: EXPERIMENTAL
Intervention: NET+VOC
Number of subjects: 72
Study 17669629 — intervention group
Group type: COMPARATOR
Intervention: VOC
Number of subjects: 72
Study 15136963 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure with massage for 12 minutes per day, three days per week, for four weeks
Number of subjects: 62
Study 15136963 — intervention group
Group type: COMPARATOR
Intervention: Routine unit care (Control)
Number of subjects: 62
Study 15136963 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure with massage
Number of subjects: 62
Study 11157665 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide synthesis inhibitor N:(G)monomethyl‐L‐arginine (5.3+/‐1.2%)
Number of subjects: 0
Study 11157665 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged episodes of reactive hyperemia, hand warming, or incremental infusion of acetylcholine
Number of subjects: 0
Study 11157665 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient hyperemia
Number of subjects: 0
Study 11157665 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained hyperemia
Number of subjects: 0
Study 9128028 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine 150 micrograms before incision
Number of subjects: 159
Study 9128028 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine 150 micrograms 60-90 min prior to arrival in the operating room
Number of subjects: 159
Study 9128028 — intervention group
Group type: COMPARATOR
Intervention: Control group (no clonidine)
Number of subjects: 159
Study 9128028 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 159
Study 7966500 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 3295020 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol (66.7 g/100 ml)
Number of subjects: 9
Study 3295020 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (66.7 ml (44.5 g)/100 ml)
Number of subjects: 9
Study 41550 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10
Study 41550 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 10
Study 31968207 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrier phrase present (VA-1 speaker)
Number of subjects: 72
Study 31968207 — intervention group
Group type: COMPARATOR
Intervention: Carrier phrase absent (VA-1 speaker)
Number of subjects: 72
Study 31968207 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrier phrase present (VA-2 speaker)
Number of subjects: 72
Study 31968207 — intervention group
Group type: COMPARATOR
Intervention: Carrier phrase absent (VA-2 speaker)
Number of subjects: 72
Study 31351085 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT & occupational therapy
Number of subjects: 12
Study 31351085 — intervention group
Group type: COMPARATOR
Intervention: BoNT therapy alone
Number of subjects: 12
Study 28053265 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 273
Study 28053265 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 273
Study 25793765 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin regimen
Number of subjects: 99
Study 25793765 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia
Number of subjects: 99
Study 25793765 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC values in the clinically relevant penumbra
Number of subjects: 99
Study 25793765 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor prognosis
Number of subjects: 99
Study 25793765 — intervention group
Group type: EXPERIMENTAL
Intervention: No arterial recanalization
Number of subjects: 99
Study 23672353 — intervention group
Group type: EXPERIMENTAL
Intervention: Qishen Yiqi dripping pills (QSYQ)
Number of subjects: 640
Study 23672353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640
Study 21872452 — intervention group
Group type: EXPERIMENTAL
Intervention: Catecholamine depletion (CD) using oral alpha‐methyl‐para‐tyrosine
Number of subjects: 28
Study 21872452 — intervention group
Group type: EXPERIMENTAL
Intervention: Catecholamine depletion (CD)
Number of subjects: 28
Study 21872452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 19141997 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol treatment under DCa = 3.5 mEq/l
Number of subjects: 12
Study 19141997 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol treatment under DCa = 3.0 mEq/l
Number of subjects: 12
Study 19141997 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol treatment under DCa = 2.5 mEq/l
Number of subjects: 12
Study 19141997 — intervention group
Group type: COMPARATOR
Intervention: Control (DCa not specified)
Number of subjects: 12
Study 17572962 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Living Every Day (ALED) program
Number of subjects: 30
Study 15276192 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic scale based on liver and lung metastases, functional performance status, weight loss, edema, cognitive impairment, tiredness, and ascites
Number of subjects: 540
Study 11372675 — intervention group
Group type: EXPERIMENTAL
Intervention: Certoparin (6.0 kDa)
Number of subjects: 0
Study 11372675 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) (13.0 kDa)
Number of subjects: 0
Study 11372675 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (4.5 kDa)
Number of subjects: 0
Study 11372675 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium molecular weight heparin (HF) (10.5 kDa)
Number of subjects: 0
Study 11372675 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparins (general)
Number of subjects: 0
Study 9505918 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 16
Study 9505918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8159637 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 IU/ml preparation of growth hormone
Number of subjects: 9
Study 8159637 — intervention group
Group type: EXPERIMENTAL
Intervention: 56 IU/ml preparation of growth hormone
Number of subjects: 9
Study 8159637 — intervention group
Group type: COMPARATOR
Intervention: Both preparations
Number of subjects: 9
Study 3346087 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise exposure (60, 85, or 90 dB (A) white noise) with task demand (task presence)
Number of subjects: 40
Study 3346087 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise exposure (60, 85, or 90 dB (A) white noise) with task absence
Number of subjects: 40
Study 3346087 — intervention group
Group type: EXPERIMENTAL
Intervention: Task demand (mental arithmetic for 3 min and abacus arithmetic for 30 min)
Number of subjects: 40
Study 3346087 — intervention group
Group type: COMPARATOR
Intervention: Control (no task demand)
Number of subjects: 40
Study 31206934 — intervention group
Group type: EXPERIMENTAL
Intervention: SVN‐2B peptide vaccination
Number of subjects: 13
Study 31206934 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SVN‐2B peptide vaccination)
Number of subjects: 13
Study 27444642 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 162
Study 27444642 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupressure
Number of subjects: 162
Study 27444642 — intervention group
Group type: COMPARATOR
Intervention: Routine Care
Number of subjects: 162
Study 26683546 — intervention group
Group type: COMPARATOR
Intervention: Emphasis terms in warning directives (e.g., 'urgent', 'recommended')
Number of subjects: 0
Study 26683546 — intervention group
Group type: COMPARATOR
Intervention: Emphasis terms in warning directives (e.g., 'important', 'compulsory')
Number of subjects: 0
Study 23721957 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (biennial PSA testing)
Number of subjects: 13423
Study 23721957 — intervention group
Group type: COMPARATOR
Intervention: Control arm (not invited to screening)
Number of subjects: 13423
Study 23721957 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 13423
Study 23721957 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 13423
Study 21204681 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐4‐3‐2‐1 Go! counseling
Number of subjects: 524
Study 21204681 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental exposure to messaging at children's school events
Number of subjects: 524
Study 19317164 — intervention group
Group type: EXPERIMENTAL
Intervention: Dannang Recipe No. 2 (DNR2) - one dose per day starting from the previous night of operation, composed of various herbal ingredients.
Number of subjects: 360
Study 19317164 — intervention group
Group type: COMPARATOR
Intervention: Ceftizoxime sodium 2.0 g or Levofloxacin 200 mg via intravenous dripping once 0.5 h before operation and 1-3 days after operation.
Number of subjects: 360
Study 17956456 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic capacity (measured by Chester Step Test)
Number of subjects: 141
Study 17956456 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip strength
Number of subjects: 141
Study 17956456 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 141
Study 14988344 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol group (consumed alcohol)
Number of subjects: 351
Study 14988344 — intervention group
Group type: COMPARATOR
Intervention: No alcohol group (did not consume alcohol)
Number of subjects: 351
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg and Enalapril 10 mg
Number of subjects: 414
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 5 mg
Number of subjects: 414
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 10 mg
Number of subjects: 414
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg
Number of subjects: 414
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg
Number of subjects: 414
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 414
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 414
Study 11707687 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nitrendipine and enalapril
Number of subjects: 414
Study 11707687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 414
Study 9009805 — intervention group
Group type: EXPERIMENTAL
Intervention: Airpuffs to the left or right temple while viewing unpleasant pictures
Number of subjects: 96
Study 9009805 — intervention group
Group type: EXPERIMENTAL
Intervention: Airpuffs to the left or right temple while viewing pleasant pictures
Number of subjects: 96
Study 9009805 — intervention group
Group type: EXPERIMENTAL
Intervention: Airpuffs to the left or right temple while viewing neutral pictures
Number of subjects: 96
Study 9009805 — intervention group
Group type: COMPARATOR
Intervention: Comparison of left vs right side of probe presentation
Number of subjects: 96
Study 9009805 — intervention group
Group type: COMPARATOR
Intervention: Comparison of left vs right side of response
Number of subjects: 96
Study 7963143 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene administration without a meal
Number of subjects: 0
Study 7963143 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene administration with meals (varied calories and fat)
Number of subjects: 0
Study 7963143 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene administration with high dietary fat
Number of subjects: 0
Study 7963143 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene administration with high caloric content
Number of subjects: 0
Study 2961357 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 400 mg/d
Number of subjects: 14
Study 2961357 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 1600 mg/d
Number of subjects: 14
Study 2961357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2961357 — intervention group
Group type: COMPARATOR
Intervention: Etidronate
Number of subjects: 14
Study 2961357 — intervention group
Group type: COMPARATOR
Intervention: Salmon calcitonin
Number of subjects: 14
Study 29417590 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical IPV during pregnancy
Number of subjects: 400
Study 29417590 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual IPV during pregnancy
Number of subjects: 400
Study 28153051 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded digital image assessment
Number of subjects: 108
Study 28153051 — intervention group
Group type: COMPARATOR
Intervention: Unblinded assessment
Number of subjects: 108